• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环磷酰胺、阿霉素和顺铂联合治疗非小细胞支气管肺癌

[Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].

作者信息

Donnay Candil O, Jiménez Berlana U

机构信息

Servicio de Oncología Médica, Ciudad Universitaria, Madrid.

出版信息

Rev Esp Oncol. 1983;30(4):603-10.

PMID:6100970
Abstract

Twenty three patients with small non oat-cell lung cancer were treated with a combination of cyclophosphamide, adriamycin and cisplatin chemotherapy. The treatment produced 30.4 per 100 objective responses (7 cases), with complete remission in 2 cases and partial remission in 5 cases. The remission duration was 7.5 and 6 months respectively. The initial "status performans" is important for the response.

摘要

23例小细胞非燕麦型肺癌患者接受了环磷酰胺、阿霉素和顺铂联合化疗。该治疗每100例产生30.4例客观缓解(7例),其中2例完全缓解,5例部分缓解。缓解持续时间分别为7.5个月和6个月。初始“身体状况评分”对缓解情况很重要。

相似文献

1
[Treatment of non-small cell bronchopulmonary carcinoma with the combination of cyclophosphamide, adriamycin and cisplatin].环磷酰胺、阿霉素和顺铂联合治疗非小细胞支气管肺癌
Rev Esp Oncol. 1983;30(4):603-10.
2
Use of cisplatin, cyclophosphamide, vincristine, and doxorubicin for the treatment of non-small cell lung cancer.使用顺铂、环磷酰胺、长春新碱和阿霉素治疗非小细胞肺癌。
Cancer Treat Rep. 1984 Sep;68(9):1159-61.
3
A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.一项关于依达曲沙联合长春碱、阿霉素、顺铂和非格司亭(EVAC/G-CSF)用于晚期恶性肿瘤患者的剂量探索性试验:对非小细胞肺癌具有有前景的抗肿瘤活性。
Cancer J Sci Am. 1997 Sep-Oct;3(5):297-302.
4
Cis-platin, vindesine, doxorubicin and cyclophosphamide in the treatment of non-small cell bronchogenic carcinoma.顺铂、长春地辛、阿霉素及环磷酰胺治疗非小细胞支气管肺癌
J Chemother. 1989 Jul;1(4 Suppl):1205-6.
5
Increasing chemotherapy dose density and intensity: phase I trials in non-small cell lung cancer and non-Hodgkin's lymphoma.增加化疗剂量密度和强度:非小细胞肺癌和非霍奇金淋巴瘤的I期试验
Oncologist. 2005 Feb;10(2):138-49. doi: 10.1634/theoncologist.10-2-138.
6
[Multidisciplinary treatment for small cell lung cancer].
Gan To Kagaku Ryoho. 1984 Mar;11(3):474-9.
7
Cisplatin, doxorubicin, cyclophosphamide, and vindesine combination chemotherapy for non-small cell lung cancer.顺铂、阿霉素、环磷酰胺和长春地辛联合化疗治疗非小细胞肺癌。
Cancer Treat Rep. 1982 Feb;66(2):247-51.
8
[A pilot study of combination chemotherapy with cyclophosphamide, adriamycin, chronic daily dosing of oral etoposide for patients with SCLC ineligible for intensive chemotherapy].[一项针对不符合强化化疗条件的小细胞肺癌患者,采用环磷酰胺、阿霉素联合口服依托泊苷每日给药方案进行联合化疗的初步研究]
Gan To Kagaku Ryoho. 1995 Feb;22(3):389-93.
9
Cisplatin, etoposide, and vincristine combination chemotherapy in the treatment of non-small cell lung cancer.顺铂、依托泊苷和长春新碱联合化疗治疗非小细胞肺癌
Nagoya J Med Sci. 1993 Mar;55(1-4):41-6.
10
[Comparative study of three different chemotherapy protocols for advanced non-small-cell lung cancer].[三种不同化疗方案治疗晚期非小细胞肺癌的比较研究]
Zhonghua Zhong Liu Za Zhi. 1999 Mar;21(2):151-2.